2022 Women’s Venture Competition
2022 Women’s Venture Competition
The AIM-HI Accelerator Fund congratulates our 2022 Women’s Venture Competition top finalists, determined by a panel of blue-ribbon judging committee consisting of world-class life sciences industry professionals, business leaders, investors and entrepreneurs:
• First Place with distinction: Johanna Webb, President & CEO of RiverWalk Therapeutics
• Second Place: Revital Mandil-Levin, Ph.D., CEO & Co-Founder of Nanocarry Therapeutics
• Third Place: Rosa Hwang, M.D., Co-Founder of Stellanova Therapeutics
We also hosted a “People’s Choice for Best Pitch” voting campaign, asking the public to select their favorite 1-min pitch video, to spread the word about these innovative oncology startups led by women entrepreneurs. The People’s Choice winner this year went to Zeenia Kaul, Ph.D., Co-Founder, CEO & CSO of ReHava BioSciences.
Ready to do more? DONATE NOW and help us double the impact for women scientist-entrepreneurs who are creating life-saving oncology innovations!
Our Semi-Finalists
Johanna Webb
President
Revital Mandil Levin, Ph.D.
Founder & CEO
Zeenia Kaul, Ph.D.
Co-Founder, CEO & CSO
Selma Durmo, M.Pharma
CEO
Bodour Salhia, Ph.D.
Founder & CEO
Rosa Hwang, M.D.
Co-Founder
